Researchers are constantly searching for new ways to treat Canine Lymphoma, and as a result there are always a large number of new medicines and clinical studies underway.
One study that shows potential promise for the future is Monoclonal Antibody Therapy.
“Monoclonal Antibody Therapy” is a targeted therapy that looks for molecular markers on the cancer cells and tries to create drugs that target those specific markers that are unique to those cancer cells.
Basically, this treatment falls under the category of “immunotherapy,” since its goal to try to utilize immune system targets and turn on the body’s own immune system to target the specific disease.
These treatments are currently in clinical trials, and there are rumors that these new treatments, which show some potential for success, will be available on the market sometime in the not too distant future.
More useful information about Monoclonal Antibody Therapy treatments can be found on the Aratana Therapeutics website.